Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.45
-0.56 (-2.95%)
May 15, 2026, 10:47 AM EDT - Market open
Avalo Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$45.20
Upside
+144.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $62 → $55 | Buy | Maintains | $62 → $55 | +198.10% | May 14, 2026 |
| Wedbush | Wedbush | Buy Maintains $40 → $34 | Buy | Maintains | $40 → $34 | +84.28% | May 14, 2026 |
| Mizuho | Mizuho | Buy Maintains $39 → $45 | Buy | Maintains | $39 → $45 | +143.90% | May 14, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $35 | Strong Buy | Maintains | $40 → $35 | +89.70% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $48 → $60 | Buy | Maintains | $48 → $60 | +225.20% | May 11, 2026 |
| Citizens | Citizens | Buy Maintains $52 → $62 | Buy | Maintains | $52 → $62 | +236.04% | May 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +116.80% | May 6, 2026 |
| BTIG | BTIG | Strong Buy Maintains $40 → $58 | Strong Buy | Maintains | $40 → $58 | +214.36% | May 6, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +116.80% | Apr 13, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $48 | Buy | Initiates | $48 | +160.16% | Apr 9, 2026 |
| Citizens | Citizens | Buy Initiates $52 | Buy | Initiates | $52 | +181.84% | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $40 | Strong Buy | Maintains | $25 → $40 | +116.80% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +116.80% | Mar 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +171.00% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +35.50% | Jan 15, 2026 |
| Mizuho | Mizuho | Buy Initiates $39 | Buy | Initiates | $39 | +111.38% | Dec 18, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.